SCHEMBL25903646

SCHEMBL25903646

CCCOc1cnc(C(C)(C)O)nc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 1/20 0.39
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.35
PLK1 P53350 1/20 0.35
ALDH1A1 P00352 4/20 0.35
MAPT P10636 3/20 0.35
NPC1 O15118 3/20 0.35
RAB9A P51151 3/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
GAA P10253 2/20 0.35
ACACB O00763 4/20 0.34
LMNA P02545 3/20 0.34
HPGD P15428 1/20 0.34
MAPK1 P28482 1/20 0.34
TP53 P04637 1/20 0.34
CYP1A2 P05177 1/20 0.34
HSD17B10 Q99714 1/20 0.34
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25315575 0.83
SCHEMBL25903505 0.80 TDP1 (0.43) KMT2AMEN1MAPTRAB9ASMN1; SMN2
SCHEMBL17052958 0.75 CA1 (0.34) KMT2AMEN1ALDH1A1MAPTLMNA
SCHEMBL26029317 0.74 NR5A1 (0.41) LTA4HNPC1LMNATP53CYP1A2
SCHEMBL17918919 0.73 LTA4H (0.41) LTA4HKMT2AMEN1L3MBTL1PLK1
SCHEMBL26254910 0.73 LTA4H (0.41) LTA4HKMT2AMEN1L3MBTL1PLK1
SCHEMBL1697679 0.71 SMN1; SMN2 (0.42) LTA4HKMT2AMEN1L3MBTL1ALDH1A1
SCHEMBL12523720 0.71 KDM4E (0.36) L3MBTL1NPC1RAB9ASMN1; SMN2
SCHEMBL26022244 0.69 TDP1 (0.40) KMT2AMEN1MAPTRAB9ASMN1; SMN2
SCHEMBL10158177 0.69 CA12 (0.42) LTA4HL3MBTL1ALDH1A1MAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023141432-A2 APOL1 INHIBITORS AND METHODS OF USE MAZE THERAPEUTICS, INC. (US) 2023-07-27 WO disclosed